FRACTIONAL FLOW RESERVE
Dr. Priyanka Thakur
DM cardiology Resident
• Coronary angiography is the most accurate
morphologic assessment of the lumen of the
epicardial coronary arteries till date, but is
limited in gauging the functional
repercussions of coronary stenoses.
LIMITATIONS OF CORONARY
ANGIOGRAPHY
• highly subjective
• provides a 2–dimentional view of a 3-dimensional lumen.
• Severity of a stenotic lesion is reported in comparison to a
normal reference segment .
• lumenography & does not provide information regarding
vessel wall.
• An ecentric stenosis has varying appearance of severity in
different views.
FFR (Fractional
flow reserve)
Technique to evaluate the hemodynamic relevance
of coronary artery stenoses.
"the ratio of maximal flow achievable in the
stenotic coronary artery to the maximal flow
achievable in the same coronary artery if it was
normal"
• Normal value is 1 irrespective of the patient , artery or
vascular bed
• Takes into account collateral blood flow
• Stenosis specific
• FFR value ≤ 0.80 is considered significant stenosis
• Independent of prevailing Systemic haemodynamics like
heart rate , blood pressure & LV contractility
• reproducible since the microvasculature has the capacity to
vasodilate till the same extent repeatedly
• Relation between FFR & viable myocardium–
If a stenotic vessel supplies a larger viable
myocardial mass, there will be larger
hyperaemic flow during maximal vasodilation
resulting in a greater gradient between Pd & Pa
& thus , a lower value of FFR.
Therefore , the haemodynamic significance of a
lesion is dependent on its perfusion territory.
Technique
Clinical Applications
• Intermediate lesions (50 to 80 %)
• Multivessel Coronary Artery Disease
• Left-Main Coronary Artery Disease
• Tandem and bifurcation Lesions
• CABG conduit patency
CLINICAL EVIDENCE
DEFER- Deferral Versus Performance
of PCI of Non-Ischemia-Producing
Stenoses
Study Name Size
Clinical
Presentation FFR Cutoff Outcomes
DEFER
(2001)
325 patients at
14 medical
centers
Stable chest
pain and an
intermediate
stenosis without
objective
evidence of
ischemia
0.75 No benefit stenting
a non-ischemic
stenosis
FAME TRIAL - Fractional Flow
Reserve Versus Angiography for
Multivessel Evaluation
Study Size
Trial
Design
Clinical
Presentation
FFR
Cutoff Outcomes
FAME
study
( 2009)
1,005 patients at
20 medical
centers
Prospective,
randomized
Multivessel
CAD
0.80 Routine
measurement of
FFR in patients
with multivessel
CAD who are
undergoing PCI
with drug-eluting
stent significantly
reduces MACE at 1
year
FAME 2 TRIAL
• Muller et al. demonstrated good prognostication by
deferring revascularization with a negative FFR for
the long-term clinical outcome of patients with an
angiographically intermediate left anterior
descending coronary artery (LAD).
• In this study, medical treatment of patients with a
hemodynamically nonsignificant stenosis (FFR
≥0.80) in the proximal LAD was associated with an
excellent long-term clinical outcome, with survival
at 5 years, which is similar to a control group
without known CAD
FFR in Acute Coronary Syndrome
(ACS)
Study name Size
Clinical
Presentation
FFR
Cuto
ff Outcomes
Compare
Acute
2017
885 at 24
centers in
Europe and Asia
Patients with
STEMI and
multivessel
disease who had
undergone
primary PCI of
an infarct-
related coronary
artery
0.80 FFR-guided complete
revascularization of non-
infarct-related arteries in
the acute setting resulted
in lower MACE, driven
by decreased
revascularization
Indications and Guidelines for FFR
ACC/AATS/AHA/ASE/ASNC/SCAI/S
CCT/STS 2016 Appropriate Use
Criteria for Coronary
Revascularization in Patients With
Acute Coronary Syndromes:
In the presence of an asymptomatic
intermediate-severity non-culprit
artery stenosis, revascularization was
rated as “appropriate therapy,”
provided that the FFR was ≤0.80.
European Society of Cardiology (ESC)
and the European Association for
Cardio-Thoracic Surgery (EACTS)
2014
FFR to identify hemodynamically
relevant lesions in stable patients
when evidence of ischemia is not
available
FFR guided PCI in patients with
multivessel disease
ACC/AATS/AHA/ASE/ASNC/SCAI/SC
CT/STS 2017 Appropriate Use Criteria
for Coronary Revascularization in
Patients With Stable Ischemic Heart
Disease:
•Invasive measurements (such as FFR)
may be very helpful in further defining
the need for revascularization and may
substitute for stress test findings.
•FFR ≤0.80 is abnormal and is
consistent with downstream inducible
ischemia.
Fraction flow reserve

Fraction flow reserve

  • 1.
    FRACTIONAL FLOW RESERVE Dr.Priyanka Thakur DM cardiology Resident
  • 2.
    • Coronary angiographyis the most accurate morphologic assessment of the lumen of the epicardial coronary arteries till date, but is limited in gauging the functional repercussions of coronary stenoses.
  • 3.
    LIMITATIONS OF CORONARY ANGIOGRAPHY •highly subjective • provides a 2–dimentional view of a 3-dimensional lumen. • Severity of a stenotic lesion is reported in comparison to a normal reference segment . • lumenography & does not provide information regarding vessel wall. • An ecentric stenosis has varying appearance of severity in different views.
  • 4.
  • 5.
    Technique to evaluatethe hemodynamic relevance of coronary artery stenoses. "the ratio of maximal flow achievable in the stenotic coronary artery to the maximal flow achievable in the same coronary artery if it was normal"
  • 10.
    • Normal valueis 1 irrespective of the patient , artery or vascular bed • Takes into account collateral blood flow • Stenosis specific • FFR value ≤ 0.80 is considered significant stenosis • Independent of prevailing Systemic haemodynamics like heart rate , blood pressure & LV contractility • reproducible since the microvasculature has the capacity to vasodilate till the same extent repeatedly
  • 11.
    • Relation betweenFFR & viable myocardium– If a stenotic vessel supplies a larger viable myocardial mass, there will be larger hyperaemic flow during maximal vasodilation resulting in a greater gradient between Pd & Pa & thus , a lower value of FFR. Therefore , the haemodynamic significance of a lesion is dependent on its perfusion territory.
  • 13.
  • 15.
    Clinical Applications • Intermediatelesions (50 to 80 %) • Multivessel Coronary Artery Disease • Left-Main Coronary Artery Disease • Tandem and bifurcation Lesions • CABG conduit patency
  • 16.
  • 17.
    DEFER- Deferral VersusPerformance of PCI of Non-Ischemia-Producing Stenoses Study Name Size Clinical Presentation FFR Cutoff Outcomes DEFER (2001) 325 patients at 14 medical centers Stable chest pain and an intermediate stenosis without objective evidence of ischemia 0.75 No benefit stenting a non-ischemic stenosis
  • 19.
    FAME TRIAL -Fractional Flow Reserve Versus Angiography for Multivessel Evaluation Study Size Trial Design Clinical Presentation FFR Cutoff Outcomes FAME study ( 2009) 1,005 patients at 20 medical centers Prospective, randomized Multivessel CAD 0.80 Routine measurement of FFR in patients with multivessel CAD who are undergoing PCI with drug-eluting stent significantly reduces MACE at 1 year
  • 22.
  • 24.
    • Muller etal. demonstrated good prognostication by deferring revascularization with a negative FFR for the long-term clinical outcome of patients with an angiographically intermediate left anterior descending coronary artery (LAD). • In this study, medical treatment of patients with a hemodynamically nonsignificant stenosis (FFR ≥0.80) in the proximal LAD was associated with an excellent long-term clinical outcome, with survival at 5 years, which is similar to a control group without known CAD
  • 25.
    FFR in AcuteCoronary Syndrome (ACS)
  • 26.
    Study name Size Clinical Presentation FFR Cuto ffOutcomes Compare Acute 2017 885 at 24 centers in Europe and Asia Patients with STEMI and multivessel disease who had undergone primary PCI of an infarct- related coronary artery 0.80 FFR-guided complete revascularization of non- infarct-related arteries in the acute setting resulted in lower MACE, driven by decreased revascularization
  • 27.
    Indications and Guidelinesfor FFR ACC/AATS/AHA/ASE/ASNC/SCAI/S CCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes: In the presence of an asymptomatic intermediate-severity non-culprit artery stenosis, revascularization was rated as “appropriate therapy,” provided that the FFR was ≤0.80.
  • 28.
    European Society ofCardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) 2014 FFR to identify hemodynamically relevant lesions in stable patients when evidence of ischemia is not available FFR guided PCI in patients with multivessel disease
  • 29.
    ACC/AATS/AHA/ASE/ASNC/SCAI/SC CT/STS 2017 AppropriateUse Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease: •Invasive measurements (such as FFR) may be very helpful in further defining the need for revascularization and may substitute for stress test findings. •FFR ≤0.80 is abnormal and is consistent with downstream inducible ischemia.